GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar
As with many generic alternatives, formulations of compounded medications can vary, including some that use semaglutide salts rather than the base form found in name-brand medications
Based on a literature search on PubMed, the Cochrane Library, and ClinicalTrials.gov, this review aims to summarize current clinical literature on GLP-1 receptor agonists in the treatment of neurodegenerative diseases to elucidate their potential in future anti-glaucomatous treatment strategies
This is a normal part of the process and happens to almost everyone
This slow approach ensures safety while maximizing the benefits of these medications for weight loss and blood sugar control
Most patients tolerate semaglutide well with minimal or no side effects